Combating Cancer: Design and Synthesis of Dual-Warhead Tumor-Targeting Drug Conjugates

Cancer is the leading cause of death for Americans under the age of 85, and it kills about 20,000 people per day worldwide. My project entails the design and synthesis of a novel tumor-targeting drug for cancer treatment. Since this drug can leave normal cells unharmed, it would not cause significant side effects. Moreover, it can attack cancer cells which are resistant to currently available chemotherapeutic agents.

Name: Preya Shah
Stats: 17 year-old Senior from Ward Melville High School, Setauket, NY
Influential Person: My mentors, teachers, and family
Career Goal: I aspire to lead a multidisciplinary research lab, while making new discoveries, teaching, and inspiring others.
Field Interest: I came to know about cancer in 2nd grade, when I first started volunteering for cancer-related events. I wanted to help alleviate human suffering and improve the lives of cancer patients. This eventually inspired me to conduct research.

Tags: education, innovation, inspire, Intel, Intel International Science and Engineering Fair, Intel ISEF

This entry was posted on Friday, May 29th, 2009 at 3:39 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.